Aprea Therapeutics, Inc. — EFFECT Filings
6 EFFECT filings on record
This page lists all EFFECT filings submitted to the SEC by Aprea Therapeutics, Inc. (APRE), sorted by most recent first. Each row links to the full filing on EdgarLookup. Aprea Therapeutics, Inc. has filed 6 EFFECT documents with the SEC since 2019. To view all SEC filings by Aprea Therapeutics, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
3
4
424B3
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
PRE 14A
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| EFFECT | — | 9999999995-26-000871 | Mar 19, 2026 | — |
| EFFECT | — | 9999999995-25-003942 | Dec 29, 2025 | — |
| EFFECT | — | 9999999995-24-001182 | Apr 29, 2024 | — |
| EFFECT | — | 9999999995-24-000309 | Feb 2, 2024 | — |
| EFFECT | — | 9999999995-20-003335 | Nov 30, 2020 | — |
| EFFECT | — | 9999999995-19-002227 | Oct 2, 2019 | — |